Health Care: Drugs

Regeneron Pharmaceuticals Inc (REGN: NASDAQ)

$512.12 n/a | n/a%
05/28/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 2.82B 2.10B 1.38B 445.82M
Cost of Sales 152.33M 114.15M 47.52M 4.22M
Gross Operating Profit 2.67B 1.99B 1.33B 441.61M
Selling, General, and Administrative Expenses 504.76M 329.42M 210.76M 117.26M
Research & Development 1.27B 859.95M 625.55M 529.51M
Operating Income before D & A (EBITDA) 891.12M 801.23M 494.65M -205.16M
Depreciation & Amortization 52.69M 41.20M 36.94M 31.08M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -25.31M -231.00K 2.01M 3.55M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 813.12M 759.80M 459.72M -232.69M
Interest Expense 37.37M 46.44M 45.30M 21.28M
Pre-Tax Income 775.75M 713.36M 414.42M -253.97M
Income Taxes 427.67M 289.00M -335.85M -1.13M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 348.07M 424.36M 750.27M -221.76M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 348.07M 424.36M 750.27M -221.76M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 348.07M 424.36M 750.27M -221.76M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
348.07M 424.36M 750.27M -221.76M
Preferred Dividends
Net Income Available To Common 348.07M 424.36M 750.27M -221.76M
Basic EPS from Continuing Ops. 3.46 4.33 7.92 -2.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.46 4.33 7.92 -2.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.46 4.33 7.92 -2.45
Basic Normalized Net Income/Share 3.46 4.33 7.92 -2.45
EPS fr Continuing Ops. 3.07 3.81 6.50 -2.45
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.07 3.81 6.50 -2.45
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.25 0.00
EPS, Total 3.07 3.81 6.75 -2.45
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.07 3.81 6.50 -2.45
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with REGN

Latest REGN Headlines from TheStreet

More Financial News for REGN

Press Releases for REGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter